top of page

PRODUCTS
At Asteri Pharma, our focus is on specialised, complex, and rare-disease therapies—areas where innovation creates real impact and where patients often face limited treatment options. We work closely with clinicians, researchers, and global partners to bring advanced, evidence-based medicines to the ANZ region, with a commitment to timely access, high-quality engagement, and exceptional support for patients, families, and healthcare professionals.
Therapeutic areas
Our growing neurology, endocrinology, and oncology portfolio reflects this mission.

Country
Status
Information
Australia
Approved

Approved
Australia
New Zealand
Approved
LYSODREN® (mitotane)
Australia
New Zealand
Please contact Asteri Pharma for more information

Australia
Approved
bottom of page
